BRCA2 and prostate cancer: Men with germ line mutation of Tumor suppressor gene BRCA2 have a 20 fold increased risk of prostate cancer while the most common alteration in prostatic cancer is hypermethylation of glutathione S-trasferase (GSTP1) gene which down-regulates GSTP1 expression.